| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Human Recombinant AKR7A2 |
|---|
| Description | Aldo-keto reductases, such as AKR7A2, are involved in the detoxification of aldehydes and ketones. This protein can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the nonbinding AFB1 dialcohol. It may be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen. Also, it has been proposed previously to catalyze the NADPH-dependent reduction of succinic semialdehyde (SSA) to Gamma-Hydroxybutyrate in human brain. MW: 44 kDa. Purity ≥95% |
|---|
| Size | 100 μg |
|---|
| Concentration | 0.5 mg/ml |
|---|
| Applications | RUO |
|---|
| Other Names | Aldo-keto reductase family 7, member A 2, Aflatoxin B1 aldehyde reductase member 2, AFAR, AFAR1, AFB1-AR1, AKR7. |
|---|
| Gene, Accession, CAS # | AKR7A2, Gene ID: 8574, Accession: O43488 |
|---|
| Catalog # | 6335-100 |
|---|
| Price | |
|---|
| Order / More Info | Human Recombinant AKR7A2 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|